160 related articles for article (PubMed ID: 28986288)
1. Manganese exposure: Linking down-regulation of miRNA-7 and miRNA-433 with α-synuclein overexpression and risk of idiopathic Parkinson's disease.
Tarale P; Daiwile AP; Sivanesan S; Stöger R; Bafana A; Naoghare PK; Parmar D; Chakrabarti T; Krishnamurthi K
Toxicol In Vitro; 2018 Feb; 46():94-101. PubMed ID: 28986288
[TBL] [Abstract][Full Text] [Related]
2. Global DNA methylation profiling of manganese-exposed human neuroblastoma SH-SY5Y cells reveals epigenetic alterations in Parkinson's disease-associated genes.
Tarale P; Sivanesan S; Daiwile AP; Stöger R; Bafana A; Naoghare PK; Parmar D; Chakrabarti T; Kannan K
Arch Toxicol; 2017 Jul; 91(7):2629-2641. PubMed ID: 27913844
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-214 participates in the neuroprotective effect of Resveratrol via inhibiting α-synuclein expression in MPTP-induced Parkinson's disease mouse.
Wang ZH; Zhang JL; Duan YL; Zhang QS; Li GF; Zheng DL
Biomed Pharmacother; 2015 Aug; 74():252-6. PubMed ID: 26349993
[TBL] [Abstract][Full Text] [Related]
4. LncRNA SNHG1 promotes α-synuclein aggregation and toxicity by targeting miR-15b-5p to activate SIAH1 in human neuroblastoma SH-SY5Y cells.
Chen Y; Lian YJ; Ma YQ; Wu CJ; Zheng YK; Xie NC
Neurotoxicology; 2018 Sep; 68():212-221. PubMed ID: 29217406
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive investigation of aberrant microRNAs expression in cells culture model of MnCl2-induced neurodegenerative disease.
He R; Xie X; Lv L; Huang Y; Xia X; Chen X; Zhang L
Biochem Biophys Res Commun; 2017 Apr; 486(2):342-348. PubMed ID: 28302480
[TBL] [Abstract][Full Text] [Related]
6. Environmental neurotoxicant manganese regulates exosome-mediated extracellular miRNAs in cell culture model of Parkinson's disease: Relevance to α-synuclein misfolding in metal neurotoxicity.
Harischandra DS; Ghaisas S; Rokad D; Zamanian M; Jin H; Anantharam V; Kimber M; Kanthasamy A; Kanthasamy AG
Neurotoxicology; 2018 Jan; 64():267-277. PubMed ID: 28450057
[TBL] [Abstract][Full Text] [Related]
7. Geniposide reduces α-synuclein by blocking microRNA-21/lysosome-associated membrane protein 2A interaction in Parkinson disease models.
Su C; Yang X; Lou J
Brain Res; 2016 Aug; 1644():98-106. PubMed ID: 27173998
[TBL] [Abstract][Full Text] [Related]
8. High Throughput Sequencing Identifies MicroRNAs Mediating α-Synuclein Toxicity by Targeting Neuroactive-Ligand Receptor Interaction Pathway in Early Stage of Drosophila Parkinson's Disease Model.
Kong Y; Liang X; Liu L; Zhang D; Wan C; Gan Z; Yuan L
PLoS One; 2015; 10(9):e0137432. PubMed ID: 26361355
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of miR-34a, miR-141, and miR-9 in MPP+-treated differentiated PC12 cells as a model of Parkinson's disease.
Rostamian Delavar M; Baghi M; Safaeinejad Z; Kiani-Esfahani A; Ghaedi K; Nasr-Esfahani MH
Gene; 2018 Jul; 662():54-65. PubMed ID: 29631008
[TBL] [Abstract][Full Text] [Related]
10. Genetic analysis of α-synuclein 3' untranslated region and its corresponding microRNAs in relation to Parkinson's disease compared to dementia with Lewy bodies.
Tagliafierro L; Glenn OC; Zamora ME; Beach TG; Woltjer RL; Lutz MW; Chiba-Falek O
Alzheimers Dement; 2017 Nov; 13(11):1237-1250. PubMed ID: 28431219
[TBL] [Abstract][Full Text] [Related]
11. CircSNCA downregulation by pramipexole treatment mediates cell apoptosis and autophagy in Parkinson's disease by targeting miR-7.
Sang Q; Liu X; Wang L; Qi L; Sun W; Wang W; Sun Y; Zhang H
Aging (Albany NY); 2018 Jun; 10(6):1281-1293. PubMed ID: 29953413
[TBL] [Abstract][Full Text] [Related]
12. Microarray expression analysis of human dopaminergic neuroblastoma cells after RNA interference of SNCA--a key player in the pathogenesis of Parkinson's disease.
Häbig K; Walter M; Stappert H; Riess O; Bonin M
Brain Res; 2009 Feb; 1256():19-33. PubMed ID: 19135032
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA expressing profiles in A53T mutant alpha-synuclein transgenic mice and Parkinsonian.
Mo M; Xiao Y; Huang S; Cen L; Chen X; Zhang L; Luo Q; Li S; Yang X; Lin X; Xu P
Oncotarget; 2017 Jan; 8(1):15-28. PubMed ID: 27965467
[TBL] [Abstract][Full Text] [Related]
14. miR-30b protects nigrostriatal dopaminergic neurons from MPP(+)-induced neurotoxicity via SNCA.
Shen YF; Zhu ZY; Qian SX; Xu CY; Wang YP
Brain Behav; 2020 Apr; 10(4):e01567. PubMed ID: 32154657
[TBL] [Abstract][Full Text] [Related]
15. Expression of the Parkinson's Disease-Associated Gene Alpha-Synuclein is Regulated by the Neuronal Cell Fate Determinant TRIM32.
Pavlou MAS; Colombo N; Fuertes-Alvarez S; Nicklas S; Cano LG; Marín MC; Goncalves J; Schwamborn JC
Mol Neurobiol; 2017 Aug; 54(6):4257-4270. PubMed ID: 27339877
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA profiling of Parkinson's disease brains identifies early downregulation of miR-34b/c which modulate mitochondrial function.
Miñones-Moyano E; Porta S; Escaramís G; Rabionet R; Iraola S; Kagerbauer B; Espinosa-Parrilla Y; Ferrer I; Estivill X; Martí E
Hum Mol Genet; 2011 Aug; 20(15):3067-78. PubMed ID: 21558425
[TBL] [Abstract][Full Text] [Related]
17. Parkinson's disease: SNCA-, PARK2-, and LRRK2- targeting microRNAs elevated in cingulate gyrus.
Tatura R; Kraus T; Giese A; Arzberger T; Buchholz M; Höglinger G; Müller U
Parkinsonism Relat Disord; 2016 Dec; 33():115-121. PubMed ID: 27717584
[TBL] [Abstract][Full Text] [Related]
18. An Inducible Alpha-Synuclein Expressing Neuronal Cell Line Model for Parkinson's Disease1.
Vasquez V; Mitra J; Perry G; Rao KS; Hegde ML
J Alzheimers Dis; 2018; 66(2):453-460. PubMed ID: 30320583
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial ROS-mediated post-transcriptional regulation of α-synuclein through miR-7 and miR-153.
Je G; Kim YS
Neurosci Lett; 2017 Nov; 661():132-136. PubMed ID: 28986122
[TBL] [Abstract][Full Text] [Related]
20. α-Synuclein-Induced Destabilized BMAL1 mRNA Leads to Circadian Rhythm Disruption in Parkinson's Disease.
Liu JY; Xue J; Wang F; Wang YL; Dong WL
Neurotox Res; 2023 Apr; 41(2):177-186. PubMed ID: 36662411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
